References
  1. Duraturo F, Liccardo R, Rosa M, et al. Genetics, diagnosis and treatment of Lynch syndrome: Old lessons and current challenges. Oncol Lett 2019; 17(3): 3048-3054.
  2. Huang S, Durno C, and Erdman S. Lynch syndrome: a pediatric perspective. J Pediatr Gastroenterol Nutr 2014; 58(2): 144-152.
  3. Biller L, Syngal S, and Yurgelun M. Recent advances in Lynch syndrome. Fam Cancer 2019; 18(2): 211-219.
  4. Win A, Jenkins M, Buchanan D, et al. Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet 2011; 48(8): 530-534.
  5. Wang C, Wang Y, Hudghes K, et al. Penetrance of Colorectal Cancer Among Mismatch Repair Gene Mutation Carriers: A Meta-Analysis. JNCI Cancer Spectr 2020; 4(5): pkaa027.
  6. Bohaumilitzky L, Kluck K, Huneburg R, et al. The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. Gastroenterology 2021; S0016-5085(21)03805-1.
  7. Yurgelun M, Kulke M, Fuchs C, et al. Cancer Susceptibility Gene Mutations in Individuals with Colorectal Cancer. J Clin Oncol 2017; 35(1): 1086-1095.
  8. Jasperson K, Vu T, Schwab A, et al. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer 2010; 9(2): 99-107.
  9. Buendia M, Joseph S, Ng K, et al. Early Onset Colorectal Adenocarcinoma in a 15-year-old with pathogenic germline mutations inAPC and MLH1 : A Case Report. Clin Colorectal Cancer 2021; S1533-0028(21)00019-0.
  10. Buendia M, Joseph S, Ng K, et al. Early Onset Colorectal Adenocarcinoma in a 15-Year-Old with Pathogenic Germline Mutations in APC and MLH1: A Case Report. Clin Colorectal Cancer 2021; 20(3): 197-200.
  11. Self C, Suttman A, Schneider K, and Hoffman L. Lynch syndrome: further defining the pediatric spectrum. Cancer Genetics 2021; 258-259: 37-40.
  12. Pearlman R, Frankel W, Swanson B, et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Early-Onset Colorectal Cancer. JAMA Oncol 2017; 3(4): 464-471.
  13. Duraturo F, Liccardo R, Cavallo A, et al. Association of low-riskMSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects. Int J Cancer 2011; 129(7): 1643-1650.
  14. Okkels H, Sunde L, Lindorff-Larsen K, et al. Polyposis and early cancer in a patient with low penetrant mutations in MSH6 andAPC : hereditary colorectal cancer as a polygenic trait.
  15. Scheenstra R, Rijcken F, Koornstra, et al. Rapidly progressive adenomatous polyposis in a patient with germline mutations in both theAPC and MLH1 genes: the worst of two worlds. Gut 2003; 52(6): 898-899.
  16. Woodage T, King S, Wacholder S et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20, 62-65 (1998). Doi:10.1038/1722